One-year cardiovascular outcomes of drug-eluting stent versus bare-metal stent implanted in diabetic patients with acute coronary syndrome
Conclusion The results of this study support the use of DES over BMS in Taiwanese patients with DM and ACS, providing the clinical benefits of lower rates of total mortality and MACE, and without increased TVR at 1 year in a real-world setting.
Source: Journal of the Chinese Medical Association - Category: Journals (General) Source Type: research
More News: Cardiogenic Shock | Cardiology | Cardiovascular | Databases & Libraries | Diabetes | Endocrinology | General Medicine | Heart | Heart Attack | Renal Failure | Study